Currency converter
^
News Feed
News Search Topics
ОК
Use filter
You can filter your feed,
by choosing only interesting
sections.
Loading

Russia assigns good funds for treatment of oncologic diseases

November 24, 2011, 16:06 UTC+3
Thirty-five regions took part in the program in 2009-2011, and 48 other territories are to join the program until 2015, Golikova said
1 pages in this article

MOSCOW, November 24 (Itar-Tass) — A total of 27.5 billion roubles have been assigned for the realization of a program of prevention of oncologic diseases, Russian Health Minister Tatyana Golikova declared at an All- Russia conference of oncologists on Thursday. The volumes of support as well as the number of regions which are taking part in the program have been specified, the minister said. Allocations worth 27.5 billion roubles have been envisaged to complete the program until 2015, Golikova said.

Thirty-five regions took part in the program in 2009-2011, and 48 other territories are to join the program until 2015, Golikova said.

The health minister praised the effect of the program, saying that in 2010 death rates caused by oncologic diseases went 0.9 percent down with 203 cancer cases registered per 100,000 population. Death rates among children who died of oncologic diseases dropped by 8.7 percent as well, with 4.2 cancer cases per 100,000 population, the minister said. A positive dynamics continued this year as well, with 1.6 percent decline registered by now, the health minister said.

Golikova stated another positive tendency of cancer being diagnosed at an early stage. Over the past few years the number of cancer cases diagnosed at an early stage went up by two percent. Cancer was diagnosed at an early stage in 47.8 percent of cases, while in Europe the number of early diagnosed cancer patients make up 50 percent, the minister said, comparing the statistics.

Commenting on the life span of oncologic patients who survive five years after anti-oncologic therapy, Golikova said that in Russia such patients make up 51 percent, while in Europe oncologic patients beyond the five-year deadline make up 55-75 percent.

 

Show more
In other media
Реклама
Реклама